Navigation Links
Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
Date:3/26/2009

be presented at the upcoming annual meeting of ASCO in May/June.
  • MDX-1342 is a fully human anti-CD19 antibody in Phase 1 development for chronic lymphocytic leukemia (CLL). Proof-of-concept pharmacologic Phase 1 data for CLL, as well as for rheumatoid arthritis, is expected in 2009. Initiation of the Phase 1 trial in acute lymphocytic leukemia remains on track for fourth-quarter 2009.
  • MDX-1401 is a fully human non-fucosylated anti-CD30 antibody in Phase 1 development for Hodgkin Lymphoma. Interim data from the ongoing multi-dose Phase 1 trial will be presented at the upcoming annual meeting of the American Association for Cancer Research (AACR) in April.
  • MDX-1411 is a fully human anti-CD70 antibody in Phase 1 development for clear cell renal cancer and lymphoma. Additional enrollment in the expansion cohorts is expected by the end of 2009, with interim Phase 1 data expected in early 2010.
  • MDX-1203 is the first antibody-drug conjugate generated from Medarex's Antibody-Drug Conjugate (ADC) platform to reach clinical testing. Enrollment initiation in the Phase 1 trial for renal cancer remains on track for mid-2009.
  • Additional preclinical data from Medarex's ADC platform and selected ongoing research programs will be presented at the upcoming annual meeting of AACR in April.
  • In addition to the highlighted oncology portfolio, Medarex is developing a number of promising products outside of oncology, including antibodies to IP-10 and CD19 for inflammation and antibodies for infectious diseases. Throughout this year and next, Medarex anticipates a strong flow of research and development milestones, including the goal of moving one or two more antibodies into clinical development.

    About Medarex

    Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody
    '/>"/>

    SOURCE Medarex, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine news :

    1. Medarex Announces 2008 Fourth Quarter and Year End Financial Results
    2. Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009
    3. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
    4. Medarex Reviews Recent Highlights and Outlook for 2009
    5. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
    6. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
    7. Medarex Announces 2008 First Quarter Financial Results
    8. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
    9. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
    10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
    11. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... Dana Point, CA (PRWEB) , ... July 30, 2015 , ... ... the highest honors available, including the very rare “no recommendations.” No recommendations means CARF ... full compliance; this is a notation that less than 3% of all facilities receive. ...
    (Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... State-designated entity on behalf of the New Jersey Department of Health, has received ... Information Technology, an agency of the U.S. Department of Health and Human Services ...
    (Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
    (Date:7/30/2015)... ORLEANS (PRWEB) , ... July 30, 2015 , ... Author ... and take charge of their health in his new self-help book, “ Consciously Healing ... Llanos’ new book promotes a simple message: “If we take responsibility for ourselves, we ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Summer is the dry eye ... to that a particularly long, dry and hot 2015 summer season and the dry ... water advocate Sharon Kleyne will discuss the 2015 summer season and identify the primary ...
    Breaking Medicine News(10 mins):Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3
    ... Ethicon Endo-Surgery announced,today that the company ... the U.S. Food and Drug Administration (FDA) ... sedation (CAPS) system., The SEDASYS(TM) System ... to,administer minimal to moderate propofol sedation to ...
    ... Introduces Comprehensive Patient and Information Tracking System with Automatic ... ... March 27 Eklin Medical Systems, a leading,developer of digital radiography ... veterinary care,(VIA(R)), is showcasing VIA,s new Hospital Functionality and VIA Safe(TM),at ...
    ... are often involved in caring for loved one , , ... the United States is a family affair, a new ... who look after a relative or friend with Alzheimer,s ... from attending doctors, appointments to feeding and dressing their ...
    ... WASHINGTON, March 27 A town hall meeting ... together leading heart,disease and stroke prevention experts from around ... can predict how healthy we are in the,United States., ... the campus of George Washington,University, will bring together thought ...
    ... grow 75% to $42.1 million, -- ... or 50 cents per diluted share, GUANGZHOU, ... Bulletin Board: CHME) ("China Medicine" or "the Company"),a ... the counter,pharmaceuticals, traditional Chinese medicines (TCM), nutritional and,dietary- ...
    ... N.Y., March 27 Patti Ann Bengen writes,romantic ... available on,amazon.com, "The Devil,s Dance." The novelist,s first ... of cruelty and,unpredictability, as she walks you down ... like driving at full speed down a treacherous ...
    Cached Medicine News:Health News:Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3Health News:With Alzheimer's, It Takes a Family 2Health News:With Alzheimer's, It Takes a Family 3Health News:Groundbreaking Town Hall Meeting to Explore Why Race, Income and Geography Can Predict Health 2Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 3Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 4Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 5Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 6Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 7Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 8Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 9Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 10Health News:China Medicine Announces Record Fourth Quarter and Fiscal Year 2007 Results 11Health News:What's the Story With This Storyteller? 2
    (Date:7/30/2015)... BURLINGAME, Calif. , July 30, 2015 /PRNewswire/ ... Patent and Trademark Office has granted the company ... property covering Cleave,s lead molecule CB-5083. ... quinazolines as inhibitors of p97," U.S. 9,062,026, allows ... CB-5083, a first-in-class, highly selective oral inhibitor of ...
    (Date:7/30/2015)... CHICAGO , July 30, 2015 Flexpoint ... and financial services sectors, today announced that it has ... and Bryan Stuart to form Kastle Therapeutics, ... Chicago , will focus on acquiring, developing and ... needs. Target acquisition opportunities include select therapies already approved ...
    (Date:7/30/2015)... July 30, 2015  Cardinal Health today reported ... an increase of 20 percent, and non-GAAP diluted ... $1.00, an increase of 20 percent. Non-GAAP operating ... a GAAP basis, operating earnings increased 44 percent ... operations increased 29 percent to $0.88. ...
    Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 32Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 33Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 34
    ... StreamVenue Healthcare has partnered its "plug and play" ... Medicine to teach, and to better manage post-surgical patient ... surgeons and physical therapists to view cases and discuss ... cohesive communication and creates a live classroom for teaching ...
    ... Reportlinker.com announces that a new market research ... Middle East and Africa ENT Devices Market ... Middle East and Africa ENT ... Summary GlobalData,s new report, "Middle ...
    Cached Medicine Technology:StreamVenue Healthcare Connects Endoscopy Technology With Athletic Trainers 2Reportlinker Adds Middle East and Africa ENT Devices Market Outlook to 2017 2
    The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
    ... several (10 to 12) brain slices to ... while maintaining excellent viability. A mixture of ... saline. This initiates a circular flow and ... slices. Slices remain viable for hours while ...
    ... cooling water for the Vibratome 900R when it is ... in a location which has no source of tap ... thermoelectric heat pump. The reservoir tank holds seven ... 900R for up to eight hours. Water is ...
    Punch set for Advanced Tissue Arrayer, 0.6 mm...
    Medicine Products: